In this review:
ACE inhibitors linked to scleroderma renal crisis?
Abatacept vs adalimumab with background MTX
Remission-steered combination treatment in early arthritis
Evidence for high heritability of gout
Explaining diabetes risk in inflammatory disease
Oral apremilast improves PsA symptoms
Tofacitinib effective in refractory, difficult-to-treat RA
Continuation vs discontinuation of etanercept
No evidence for anti-TNFassociated lymphoma risk
Genetic variants of serum uric acid and gout
Please login below to download this issue (PDF)